US Stock MarketDetailed Quotes

DERM Journey Medical

Watchlist
  • 3.400
  • -0.100-2.86%
Close Apr 26 16:00 ET
67.77MMarket Cap-16190P/E (TTM)

Journey Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
7.48%79.18M
-4.44%15.26M
114.31%34.54M
-6.12%17.17M
-47.57%12.21M
16.69%73.67M
-8.85%15.97M
-17.82%16.12M
19.64%18.29M
117.33%23.3M
Operating revenue
-15.96%59.66M
-4.17%15.26M
-4.76%15.28M
-6.99%16.96M
-41.50%12.17M
12.52%71M
-8.92%15.92M
-18.19%16.04M
19.28%18.24M
94.01%20.8M
Cost of revenue
-13.37%26.66M
-22.07%6.02M
-10.97%6.43M
1.76%7.77M
-21.38%6.45M
-4.08%30.78M
-18.97%7.72M
-35.34%7.22M
1.99%7.63M
109.90%8.2M
Gross profit
22.44%52.52M
12.05%9.24M
216.02%28.11M
-11.76%9.41M
-61.81%5.76M
38.14%42.89M
3.20%8.25M
5.35%8.9M
36.57%10.66M
121.60%15.09M
Operating expense
-26.93%51.45M
-37.81%11.35M
-40.91%10.87M
-21.83%13.92M
-4.10%15.33M
24.86%70.41M
7.00%18.24M
59.21%18.39M
-17.47%17.8M
156.68%15.98M
Selling and administrative expenses
-26.16%43.91M
-29.64%9.84M
-44.55%8.64M
-20.08%12.14M
-9.67%13.29M
49.29%59.47M
-7.11%13.99M
44.82%15.58M
94.88%15.19M
136.35%14.72M
Research and development costs
-31.09%7.54M
-64.64%1.51M
-20.73%2.23M
-32.00%1.77M
60.58%2.03M
-33.91%10.94M
113.65%4.26M
254.16%2.81M
-81.06%2.61M
--1.27M
Operating profit
103.89%1.07M
78.95%-2.1M
281.68%17.25M
36.85%-4.51M
-976.69%-9.56M
-8.59%-27.52M
-10.36%-10M
-205.60%-9.49M
48.11%-7.14M
-251.79%-888K
Net non-operating interest income expense
29.76%-1.38M
115.70%89K
53.24%-260K
-50.44%-677K
-36.79%-528K
72.14%-1.96M
86.16%-567K
59.50%-556K
66.47%-450K
-74.66%-386K
Non-operating interest income
436.67%322K
126.00%113K
166.67%8K
1,875.00%79K
3,966.67%122K
2,900.00%60K
2,400.00%50K
--3K
--4K
--3K
Non-operating interest expense
-15.90%1.7M
-96.11%24K
-52.06%268K
66.52%756K
67.10%650K
-71.30%2.02M
-84.94%617K
-59.29%559K
-66.04%454K
76.02%389K
Other net income (expense)
-3,637.08%-3.33M
97.01%-2K
-359.09%-101K
-3.18M
-47K
99.11%-89K
74.52%-67K
99.77%-22K
Gain on sale of security
-105.62%-183K
97.01%-2K
-359.09%-101K
---33K
---47K
80.09%-89K
74.52%-67K
-1,000.00%-22K
----
----
Special income (charges)
---3.14M
--0
--0
---3.14M
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
--3.14M
--0
--0
--3.14M
----
--0
--0
--0
--0
----
Income before tax
87.72%-3.63M
81.02%-2.02M
267.67%16.88M
-10.16%-8.36M
-695.60%-10.14M
30.21%-29.57M
20.77%-10.63M
28.18%-10.07M
50.34%-7.59M
-450.00%-1.27M
Income tax
250.79%221K
869.23%126K
850.00%95K
0
0
-96.14%63K
-99.84%13K
100.30%10K
98.13%-64K
8.33%104K
Net income
87.00%-3.85M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
Net income continuous Operations
87.00%-3.85M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
Minority interest income
Net income attributable to the parent company
87.00%-3.85M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
87.00%-3.85M
79.86%-2.14M
266.56%16.79M
-11.09%-8.36M
-635.56%-10.14M
32.65%-29.63M
51.07%-10.64M
5.32%-10.08M
36.55%-7.53M
-614.18%-1.38M
Basic earnings per share
87.57%-0.21
80.00%-0.12
259.65%0.91
-6.98%-0.46
-612.50%-0.57
60.88%-1.69
63.41%-0.6
50.86%-0.57
66.80%-0.43
-373.48%-0.08
Diluted earnings per share
87.57%-0.21
80.00%-0.12
240.35%0.8
-6.98%-0.46
-612.50%-0.57
60.88%-1.69
63.41%-0.6
50.86%-0.57
66.80%-0.43
-373.48%-0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 7.48%79.18M-4.44%15.26M114.31%34.54M-6.12%17.17M-47.57%12.21M16.69%73.67M-8.85%15.97M-17.82%16.12M19.64%18.29M117.33%23.3M
Operating revenue -15.96%59.66M-4.17%15.26M-4.76%15.28M-6.99%16.96M-41.50%12.17M12.52%71M-8.92%15.92M-18.19%16.04M19.28%18.24M94.01%20.8M
Cost of revenue -13.37%26.66M-22.07%6.02M-10.97%6.43M1.76%7.77M-21.38%6.45M-4.08%30.78M-18.97%7.72M-35.34%7.22M1.99%7.63M109.90%8.2M
Gross profit 22.44%52.52M12.05%9.24M216.02%28.11M-11.76%9.41M-61.81%5.76M38.14%42.89M3.20%8.25M5.35%8.9M36.57%10.66M121.60%15.09M
Operating expense -26.93%51.45M-37.81%11.35M-40.91%10.87M-21.83%13.92M-4.10%15.33M24.86%70.41M7.00%18.24M59.21%18.39M-17.47%17.8M156.68%15.98M
Selling and administrative expenses -26.16%43.91M-29.64%9.84M-44.55%8.64M-20.08%12.14M-9.67%13.29M49.29%59.47M-7.11%13.99M44.82%15.58M94.88%15.19M136.35%14.72M
Research and development costs -31.09%7.54M-64.64%1.51M-20.73%2.23M-32.00%1.77M60.58%2.03M-33.91%10.94M113.65%4.26M254.16%2.81M-81.06%2.61M--1.27M
Operating profit 103.89%1.07M78.95%-2.1M281.68%17.25M36.85%-4.51M-976.69%-9.56M-8.59%-27.52M-10.36%-10M-205.60%-9.49M48.11%-7.14M-251.79%-888K
Net non-operating interest income expense 29.76%-1.38M115.70%89K53.24%-260K-50.44%-677K-36.79%-528K72.14%-1.96M86.16%-567K59.50%-556K66.47%-450K-74.66%-386K
Non-operating interest income 436.67%322K126.00%113K166.67%8K1,875.00%79K3,966.67%122K2,900.00%60K2,400.00%50K--3K--4K--3K
Non-operating interest expense -15.90%1.7M-96.11%24K-52.06%268K66.52%756K67.10%650K-71.30%2.02M-84.94%617K-59.29%559K-66.04%454K76.02%389K
Other net income (expense) -3,637.08%-3.33M97.01%-2K-359.09%-101K-3.18M-47K99.11%-89K74.52%-67K99.77%-22K
Gain on sale of security -105.62%-183K97.01%-2K-359.09%-101K---33K---47K80.09%-89K74.52%-67K-1,000.00%-22K--------
Special income (charges) ---3.14M--0--0---3.14M------0--0--0--0----
-Less:Impairment of capital assets --3.14M--0--0--3.14M------0--0--0--0----
Income before tax 87.72%-3.63M81.02%-2.02M267.67%16.88M-10.16%-8.36M-695.60%-10.14M30.21%-29.57M20.77%-10.63M28.18%-10.07M50.34%-7.59M-450.00%-1.27M
Income tax 250.79%221K869.23%126K850.00%95K00-96.14%63K-99.84%13K100.30%10K98.13%-64K8.33%104K
Net income 87.00%-3.85M79.86%-2.14M266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M
Net income continuous Operations 87.00%-3.85M79.86%-2.14M266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M
Minority interest income
Net income attributable to the parent company 87.00%-3.85M79.86%-2.14M266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 87.00%-3.85M79.86%-2.14M266.56%16.79M-11.09%-8.36M-635.56%-10.14M32.65%-29.63M51.07%-10.64M5.32%-10.08M36.55%-7.53M-614.18%-1.38M
Basic earnings per share 87.57%-0.2180.00%-0.12259.65%0.91-6.98%-0.46-612.50%-0.5760.88%-1.6963.41%-0.650.86%-0.5766.80%-0.43-373.48%-0.08
Diluted earnings per share 87.57%-0.2180.00%-0.12240.35%0.8-6.98%-0.46-612.50%-0.5760.88%-1.6963.41%-0.650.86%-0.5766.80%-0.43-373.48%-0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg